Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis
Tzouvelekis, Argyris, Herazo‐Maya, Jose D., Slade, Martin, Chu, Jen‐hwa, Deiuliis, Giuseppe, Ryu, Changwan, Li, Qin, Sakamoto, Koji +6 more·2017·Respirology
Cited by (130)
Items 101–130 of 130
- Prognostic Value of Combined Detection of MMP ‐7 and ALP Levels in Children With Biliary Atresia Post‐Kasai SurgeryQingzhi Li, Chaoxiang Ye, Wei Gao · 2025 · Pediatric Transplantation
- Molecular Biomarkers in Interstitial Lung DiseasesUmberto Zanini, Paola Faverio, Fabrizio Luppi · 2025 · Respiratory medicine
- Mediators of monocyte chemotaxis and matrix remodeling are associated with the development of fibrosis in patients with COVID-19Sarah E. Holton, Mallorie A. Mitchem, Sudhakar J. Pipavath, Eric D. Morrell, Pavan K. Bhatraju, Jessica A. Hamerman, Cate Speake, Uma Malhotra, Mark M. Wurfel, Steven F. Ziegler et al. · 2023 · medRxiv
- “An Ounce of Prevention.. ”: Will This Be the Future for Idiopathic Pulmonary Fibrosis?Joyce Sujin Lee · 2017 · American Journal of Respiratory and Critical Care Medicine
- Year in review 2017: Interstitial lung disease, pulmonary vascular disease and sleepAmanda Jane Piper, Stephen John Wort, Elisabetta Augusta Renzoni, Vasileios Kouranos · 2018 · Respirology
- Biomarker discovery and drug testing in Idiopathic Pulmonary FibrosisIsis E. Fernandez · 2018 · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)
- Summary and Future Applications of Precision Medicine in Pulmonary, Critical Care, and Sleep MedicineJosé L. Gómez, Naftali Kaminski, Blanca E. Himes · 2020 · Respiratory medicine
- Research Progress of Prognostic Biomarkers in Idiopathic Pulmonary Fibrosis静 任 · 2022 · Advances in Clinical Medicine
- Uloga matriks metaloproteinaza u razvoju bolesti uzrokovanih čimbenicima okolišaIvana Šutić, Marija Bubaš, Aleksandar Bulog · 2023 · Sigurnost
- Research Progress of MMP-1, MMP-7 and MMP-9 in Idiopathic Pulmonary Interstitial Fibrosis西苓 侯 · 2023 · Advances in Clinical Medicine
- Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial InjuryIain D. Stewart, Joseph Jacob, Joanna C. Porter, Richard J. Allen, John Blaikley, Nazia Chaudhuri, Emma Kate Denneny, Laura Fabbri, Peter Myles George, Beatriz Guillén‐Guío et al. · 2024 · SSRN Electronic Journal
- Matrix metalloproteinase 7 as a diagnostic biomarker of biliary atresia: A systematic reviewPauline Louise Møllmann Lausten, Vibeke Brix Christensen, Hannelouise Kissow · 2024 · Advances in Biomarker Sciences and Technology
- PREDICTION OF PULMONARY FIBROSIS AND THE DEVELOPMENT OF CHRONIC PULMONARY INSUFFICIENCY IN PATIENTS WHO HAVE UNDERGONE COVID-19Diana B. Balinyan, Olga Alekseevna Efremova, Л А Камышникова, Vladislav A. Dubrova, Aleksey Yu. Blagov · 2024 · Siberian Journal of Life Sciences and Agriculture
- Additional file 8 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 7 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 4 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 2 of NHLRC2 expression is increased in idiopathic pulmonary fibrosisMervi Kreus, Siri T. Lehtonen, Reetta Hinttala, Johanna Salonen, Katja Porvari, Kaarteenaho, Riitta · 2022 · Figshare
- Additional file 5 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 1 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 1 of NHLRC2 expression is increased in idiopathic pulmonary fibrosisMervi Kreus, Siri T. Lehtonen, Reetta Hinttala, Johanna Salonen, Katja Porvari, Kaarteenaho, Riitta · 2022 · Figshare
- Additional file 3 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 2 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Additional file 1 of Biomarkers of cellular senescence in idiopathic pulmonary fibrosisZaira Aversa, Atkinson, Elizabeth J., Eva Carmona, Thomas A. White, Amanda A. Heeren, Sarah K. Jachim, Zhang, Xu, Cummings, Steven R., Sergio E. Chiarella, ANDREW HAR LIMPER et al. · 2023 · Figshare
- Additional file 6 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L. Todd, Richard Vinisko, Liu, Yi, Megan Lee Neely, Robert A. Overton, Flaherty, Kevin R., Noth, Imre, Laura Kristin Newby, Joseph A. Lasky, Mitchell A. Olman et al. · 2020 · Figshare
- Identification de marqueurs d’exposition et d’effets de nanoparticules métalliques sur modèle in vitroZahra Manel Doumandji · 2019 · theses.fr (ABES)
- Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysisKyeongmin Kim, Jinwoo Seok, Hee‐Young Yoon · 2026 · Pulmonology
- Патогенетические аспекты, современные подходы в диагностике интерстициальных заболеваний легких с прогрессирующим фиброзомЛ.К. Суркова, Е. И. Давидовская, О.А. Будник, Е.Д. Протько, Л.С. Богуш, О.Г. Карпелёва, О.В. Тарасов · 2026 · Рецепт
- Clinical impact of hospitalization in patients with idiopathic pulmonary fibrosis: A retrospective cohort studyMin Jee Kim, Hyun Seok Kwak, Sehee Kim, Ho Cheol Kim · 2026 · Therapeutic Advances in Respiratory Disease
- MMP-7 as a non-invasive biomarker in interstitial lung diseases and other chronic respiratory diseases: a narrative reviewMarian Marius Padureanu, ILEANA MARINESCU, Denisa Maria Mitroi, Radu Mihai Coanda, Simona-Maria Roșu, Ana Stefania Stoica, Mihnea Marian Pomacu, Sorina Ionelia Stan, Alina Croitoru, Simona Bănicioiu-Covei et al. · 2026 · Frontiers in Medicine
- Prospects of combined biomarker indices for the diagnosis of progressive pulmonary fibrosis in patients with hypersensitivity pneumonitisБолотова Елена Валентиновна, Yu. G. Yurkova, И. В. Гилевич, Larisa V. Shulzhenko · 2026 · PULMONOLOGIYA